Metabolic Syndrome, Inflammation and Atherosclerosis

References

• AlbertMADanielsonERifaiNEffect of statin therapy on C-reactive protein levels – the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort studyJAMA2001286647011434828
   PubMed Web of Science ®Google Scholar
• AlbertiKGZimmetPZDefinition, diagnosis and classification of diabetes mellitus and its complications – part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultationDiab Med19981553953
   PubMed Web of Science ®Google Scholar
• BergerJPAkiyamaTEMeinkePTPPARs: therapeutic targets for metabolic diseaseTrends Pharmacol Sci2005262445115860371
   PubMed Web of Science ®Google Scholar
• BuchananTAXiangAHPetersRKPreservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic womenDiabetes200251279680312196473
   PubMed Web of Science ®Google Scholar
• CabreroALagunaJCVazquezMPeroxisome proliferatoractivated receptors and the control of inflammationCurr Drug Targets Inflamm Allergy20021243814561188
   PubMedGoogle Scholar
• CannerPLFurbergCDTerrinMLBenefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)Am J Cardiol200595254715642562
   PubMed Web of Science ®Google Scholar
• Chinetti-GbaguidiGFruchartJCStaelsBRole of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapyCurr Opin Pharmacol200551778315780828
   PubMed Web of Science ®Google Scholar
• DandonaPAljadaABandyopadhyayAInflammation: the link between insulin resistance, obesity and diabetesTrends Immunol2004254714698276
   PubMed Web of Science ®Google Scholar
• DandonaPAljadaAChaudhuriAMetabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammationCirculation200511114485415781756
   PubMed Web of Science ®Google Scholar
• de FerrantiSDGauvreauKLudwigDSPrevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination SurveyCirculation20041102494715477412
   PubMed Web of Science ®Google Scholar
• DunstanDWZimmetPZWelbornTAThe rising prevalence of diabetes and impaired glucose tolerance – the Australian Diabetes, Obesity and Lifestyle StudyDiabetes Care2002258293411978676
   PubMed Web of Science ®Google Scholar
• DurbinRJThiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistanceDiab Obes Metab200462805
   PubMed Web of Science ®Google Scholar
• EckelRHGrundySMZimmetPZThe metabolic syndromeLancet200536514152815836891
   PubMed Web of Science ®Google Scholar
• EspositoKMarfellaRCiotolaMEffect of a Mediterraneanstyle diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trialJAMA20042921440615383514
   PubMed Web of Science ®Google Scholar
• FestaAD'AgostinoRJrHowardGChronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)Circulation200010242710880413
   PubMed Web of Science ®Google Scholar
• FordESGilesWHDietzWHPrevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination SurveyJAMA2002287356911790215
   PubMed Web of Science ®Google Scholar
• GaedePVedelPLarsenNMultifactorial intervention and cardiovascular disease in patients with type 2 diabetesN Engl J Med20033483839312556541
   PubMed Web of Science ®Google Scholar
• GoodpasterBHKrishnaswamiSHarrisTBObesity, regional body fat distribution, and the metabolic syndrome in older men and womenArch Intern Med20051657778315824297
   PubMed Web of Science ®Google Scholar
• HanssonGKInflammation, atherosclerosis, and coronary artery diseaseN Engl J Med200535216859515843671
   PubMed Web of Science ®Google Scholar
• HuGQiaoQTuomilehtoJPrevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and womenArch Intern Med200416410667615159263
   PubMed Web of Science ®Google Scholar
• IsomaaBAlmgrenPTuomiTCardiovascular morbidity and mortality associated with the metabolic syndromeDiabetes Care200124683911315831
   PubMed Web of Science ®Google Scholar
• KahnRBuseJFerranniniEThe metabolic syndrome: time for a critical appraisal – joint statement from the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care200528228930416123508
   PubMed Web of Science ®Google Scholar
• LaaksonenDENiskanenLNyyssonenKC-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged menDiabetologia20044714031015309290
   PubMed Web of Science ®Google Scholar
• LakkaHMLaaksonenDELakkaTAThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged menJAMA200228827091112460094
   PubMed Web of Science ®Google Scholar
• MeksawanKVenkatramanJTAwadABEffect of dietary fat intake and exercise on inflammatory mediators of the immune system in sedentary men and womenJ Am Coll Nutr2004233314015310737
   PubMed Web of Science ®Google Scholar
• [NCEP] Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adultsExecutive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• NieuwdorpMStroesESMeijersJCHypercoagulability in the metabolic syndromeCurr Opin Pharmacol20055155915780824
   PubMed Web of Science ®Google Scholar
• NishimuraFMurayamaYPeriodontal inflammation and insulin resistance – lessons from obesityJ Dent Res2001801690411669476
   PubMed Web of Science ®Google Scholar
• NishimuraFSogaYIwamotoYPeriodontal disease as part of the insulin resistance syndrome in diabetic patientsJ Int Acad Periodontol20057162015736891
   PubMedGoogle Scholar
• NissenSETuzcuEMSchoenhagenPStatin therapy, LDL cholesterol, C-reactive protein, and coronary artery diseaseN Engl J Med2005352293815635110
   PubMed Web of Science ®Google Scholar
• OrchardTJTemprosaMGoldbergRThe effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trialAnn Intern Med20051426111915838067
   PubMed Web of Science ®Google Scholar
• ReillyMPLehrkeMWolfeMLResistin is an inflammatory marker of atherosclerosis in humansCirculation2005111932915710760
   PubMed Web of Science ®Google Scholar
• ReillyMPRaderDJThe metabolic syndrome: more than the sum of its parts?Circulation200310815465114517150
   PubMed Web of Science ®Google Scholar
• RidkerPMBuringJECookNRC-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American womenCirculation2003107391712551861
   PubMed Web of Science ®Google Scholar
• RidkerPMCannonCPMorrowDC-reactive protein levels and outcomes after statin therapyN Engl J Med200535220815635109
   PubMed Web of Science ®Google Scholar
• RidkerPMClinical application of C-reactive protein for cardiovascular disease detection and preventionCirculation2003107363912551853
   PubMed Web of Science ®Google Scholar
• RobinsSJRubinsHBFaasFHInsulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)Diabetes Care20032615131712716814
   PubMed Web of Science ®Google Scholar
• RobinsSJCardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?Curr Opin Lipidol2003145758314624134
   PubMed Web of Science ®Google Scholar
• SattarNGawAScherbakovaOMetabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention StudyCirculation20031084141912860911
   PubMed Web of Science ®Google Scholar
• SavageDBTanGDAceriniCLHuman metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-γDiabetes2003529101712663460
   PubMed Web of Science ®Google Scholar
• ShmulewitzDAuerbachSBLehnerTEpidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of MicronesiaHum Hered20015181911096265
   PubMed Web of Science ®Google Scholar
• StaelsBFruchartJCTherapeutic roles of peroxisome proliferatoractivated receptor agonistsDiabetes20055424607016046315
   PubMed Web of Science ®Google Scholar
• SternMWilliamsKGonzalez-VillalpandoCDoes the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?Diabetes Care20042726768115505004
   PubMed Web of Science ®Google Scholar
• TaylorAJLeeHYGraceKARelationship between diabetic status and progression of carotid atherosclerosis after the addition of extended-release niacin to statin monotherapyJ Am Coll Cardiol200545Suppl. A3A
   Google Scholar
• TaylorAJSullenbergerLELeeHJArterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2 – a double-blind, placebo-controlled study of extendedrelease niacin on atherosclerosis progression in secondary prevention patients treated with statinsCirculation200411035121715537681
   PubMed Web of Science ®Google Scholar
• TenenbaumAMotroMFismanEZBezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndromeArch Intern Med200516511546015911729
   PubMed Web of Science ®Google Scholar
• TordjmanKBernal-MizrachiCZemanyLPPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null miceJ Clin Invest200110710253411306606
   PubMed Web of Science ®Google Scholar
• VermaSLiSHWangCHResistin promotes endothelial cell activation: further evidence of adipokine-endothelial interactionCirculation20031087364012874180
   PubMed Web of Science ®Google Scholar
• WeissRDziuraJBurgertTSObesity and the metabolic syndrome in children and adolescentsN Engl J Med200435023627415175438
   PubMed Web of Science ®Google Scholar
• XydakisAMCaseCCJonesPHAdiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restrictionJ Clin Endocrinol Metab200489269770315181044
   PubMed Web of Science ®Google Scholar
• YokotaTOritaniKTakahashiIAdiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophagesBlood20009617233210961870
   PubMed Web of Science ®Google Scholar
• ZellerMStegPGRavisyJPrevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarctionArch Intern Med20051651192815911735
   PubMedGoogle Scholar